Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease-Reference-Cited by-同舟云学术

Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease

Published:2020-11-05 Issue:2 Volume:57 Page:2003079
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

O'Shea Kate M.,O'Carroll Orla M.,Carroll Catherine,Grogan Brenda,Connolly Anna,O'Shaughnessy Lynda,Nicholson Trevor T.,Gallagher Charles G.,McKone Edward F.

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference12 articles.

1. The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy;Lommatzsch;Ther Adv Respir Dis,2019

2. CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine;Lopes-Pacheco;Front Pharmacol,2019

3. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

4. Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

5. Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease;Annals of the American Thoracic Society;2024-07

2. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians;Current Problems in Pediatric and Adolescent Health Care;2024-06

3. Efficacy and safety profile of elexacaftor-tezacaftor-ivacaftor triple therapy on cystic fibrosis: a systematic review and single arm meta-analysis;Frontiers in Pharmacology;2023-12-14

4. Long-term clinical outcomes of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis and advanced pulmonary disease;Respiratory Medicine;2023-11

5. Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis;Pulmonary Pharmacology & Therapeutics;2023-10